<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04126096</url>
  </required_header>
  <id_info>
    <org_study_id>19-002587</org_study_id>
    <nct_id>NCT04126096</nct_id>
  </id_info>
  <brief_title>Negative Predictive Value and NIC of Beta-Lactam Antibiotics.</brief_title>
  <official_title>The Negative Predictive Value and Non-irritant Skin Testing Concentrations of Beta-Lactam Containing Antibiotics Other Than Penicillin.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The researchers are trying to evaluate how much medication is required for allergy skin&#xD;
      testing and to determine the likelihood that patients with a negative test truly don't have&#xD;
      an allergy to the tested drug of skin testing to commonly used antibiotics.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a prospective study to accurately determine the negative predictive value&#xD;
      of skin testing with beta lactam containing antibiotics other than penicillin .&#xD;
&#xD;
      It is hypothesized that the concentrations that should be used for beta lactams are actually&#xD;
      much lower than previously recommended and that the higher incidence of identifiable beta&#xD;
      lactam induced allergic reactions during anesthesia in the past may be due to irritation of&#xD;
      the skin rather than a true allergic reaction (false positives).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 20, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Skin testing</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Non-Irritant Concentrations to common beta lactam containing antibiotics other than penicillin</measure>
    <time_frame>1 Year</time_frame>
    <description>Determine the NIC to common beta lactam containing antibiotics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Negative Predictive Value of Intradermal Skin Testing to commonly used beta lactam containing antibiotics other than penicillin</measure>
    <time_frame>1 Year</time_frame>
    <description>Determine Negative Predictive Value of Intradermal Skin Testing to commonly used beta lactam containing antibiotics</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Max Concentration used when skin testing to beta lactam containing antibiotics other than penicillin</measure>
    <time_frame>1 Year</time_frame>
    <description>Close gap on the variability of the maximal concentration used when skin testing beta lactam containing antibiotics.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Allergy</condition>
  <arm_group>
    <arm_group_label>Study Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study team is developing a new diagnostic skin testing procedure for patients who receive beta lactam containing antibiotics during surgery (other than penicillin) in order to determine Negative Predictive Values and Non-Irritant Concentrations.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Skin Testing beta-lactams</intervention_name>
    <description>Percutaneous skin prick followed by Intradermal Injections of NMBAs at increasing concentrations compared with an established positive and negative control.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All adults &gt; or = to 18 y/o undergoing surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Minors under the age of 18 y/o, Adults unable to consent, or those Adults with&#xD;
             previous allergic reaction history during previous surgeries.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexei Gonzalez Estrada, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexei Gonzalez Estrada, M.D.</last_name>
      <phone>904-953-2451</phone>
      <email>gonzalez.alexei@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ismael Carrillo-Martin, M.D.</last_name>
      <phone>904-953-3767</phone>
      <email>Carrillo-Martin@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Alexei Gonzalez Estrada, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ismael Carrillo-Martin, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexei Gonzalez Estrada, M.D.</last_name>
      <phone>904-953-2451</phone>
      <email>gonzalez.alexei@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ismael Carrillo-Martin, M.D.</last_name>
      <phone>904-953-3767</phone>
      <email>Carrillo-Martin.Isamel@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Alexei Gonzalez Estrada, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ismael Carrillo-Martin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 11, 2019</study_first_submitted>
  <study_first_submitted_qc>October 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2019</study_first_posted>
  <last_update_submitted>August 18, 2021</last_update_submitted>
  <last_update_submitted_qc>August 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Alexei Gonzalez-Estrada, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactams</mesh_term>
    <mesh_term>beta-Lactams</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

